Inventor · disambiguated record
Jeffrey O. Saunders
Also filed as: SAUNDERS JEFFREY · SAUNDERS JEFFREY O · SAUNDERS JEFFREY OWEN
68 granted patents·32 pending applications·2,304 citations·filing 1989–2024
99Inventor score
Files withAGIOS PHARMACEUTICALS INC29VERTEX PHARMA26SALITURO FRANCESCO G10ELIXIR PHARMACEUTICALS INC5SAUNDERS JEFFREY O5
Top patents by PatentIndex Score
100 records- 0199US6054472AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Apr 25, 2000·242 cites·12 claims
- 0298US8785450B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2010·Granted Jul 22, 2014·45 cites·51 claims
- 0398US6653309B1Inhibitors of IMPDH enzyme technical field of the inventionVERTEX PHARMA·Filed 2000·Granted Nov 25, 2003·131 cites·19 claims
- 0498US5807876AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1996·Granted Sep 15, 1998·304 cites·21 claims
- 0597US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
- 0697US8889667B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2011·Granted Nov 18, 2014·28 cites·11 claims
- 0797US8742119B2Pyruvate kinase M2 modulators, therapeutic compositions and related methods of useSALITURO FRANCESCO G·Filed 2011·Granted Jun 3, 2014·39 cites·14 claims
- 0897US6498178B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2001·Granted Dec 24, 2002·174 cites·45 claims
- 0996US10029987B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jul 24, 2018·9 cites·24 claims
- 1096US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
- 1196US6541496B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2000·Granted Apr 1, 2003·80 cites·12 claims
- 1296US6344465B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Feb 5, 2002·186 cites·9 claims
- 1396US5620971ABiologically active acylated amino acid derivativesVERTEX PHARMA·Filed 1994·Granted Apr 15, 1997·88 cites·27 claims
- 1496US5516797AImmunosuppressive compoundsVERTEX PHARMA·Filed 1994·Granted May 14, 1996·121 cites·8 claims
- 1596US5330993AImmunosuppressive compoundsVERTEX PHARMA·Filed 1991·Granted Jul 19, 1994·143 cites·1 claims
- 1696US5192773AImmunosuppressive compoundsVERTEX PHARMA·Filed 1990·Granted Mar 9, 1993·163 cites·10 claims
- 1794US10610125B2Methods and compositions for cell-proliferation-related disordersAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 1894US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
- 1994US9328077B2Bicyclic PKM2 activatorsSALITURO FRANCESCO G·Filed 2011·Granted May 3, 2016·21 cites·29 claims
- 2093US9199968B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2014·Granted Dec 1, 2015·10 cites·16 claims
- 2192US9458132B2Therapeutic compounds and compositions and their use as PKM2 modulatorsAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 4, 2016·18 cites·25 claims
- 2291US9221792B2N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulatorsSALITURO FRANCESCO G·Filed 2011·Granted Dec 29, 2015·17 cites·14 claims
- 2391US8501953B2PKM2 modulators for use in the treatment of cancerSALITURO FRANCESCO G·Filed 2011·Granted Aug 6, 2013·19 cites·18 claims
- 2490US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
- 2590US2025378926A1Methods and compositions for cell-proliferation-related disordersSERVIER PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 2689US12428376B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Sep 30, 2025·0 cites·5 claims
- 2789US9029531B2Compounds and their methods of useLEMIEUX RENE M·Filed 2013·Granted May 12, 2015·8 cites·20 claims
- 2889US7989498B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Granted Aug 2, 2011·19 cites·1 claims
- 2989US5622970AImmunosuppressive compoundsVERTEX PHARMA·Filed 1995·Granted Apr 22, 1997·61 cites·10 claims
- 3087US7329681B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2005·Granted Feb 12, 2008·8 cites·11 claims
- 3186US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
- 3286US5665774AImmunosuppressive compoundsFiled 1993·Granted Sep 9, 1997·42 cites·18 claims
- 3385US7829589B2Sulfonamide compounds and uses thereofELIXIR PHARMACEUTICALS INC·Filed 2006·Granted Nov 9, 2010·12 cites·16 claims
- 3484US5717092ACompounds with improved multi-drug resistance activityVERTEX PHARMA·Filed 1996·Granted Feb 10, 1998·54 cites·3 claims
- 3583US9303002B2Compounds and their methods of useLEMIEUX RENE M·Filed 2013·Granted Apr 5, 2016·6 cites·15 claims
- 3683US2024071588A1Methods and compositions for cell-proliferation-related disordersSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 3782US7087642B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2002·Granted Aug 8, 2006·13 cites·28 claims
- 3882US2023250078A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 3981US6967214B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Granted Nov 22, 2005·12 cites·38 claims
- 4081US5723459ABiologically active acylated amino acid derivativesVERTEX PHARMA·Filed 1995·Granted Mar 3, 1998·28 cites·28 claims
- 4180US5099035AMevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing sameSQUIBB & SONS INC·Filed 1991·Granted Mar 24, 1992·20 cites·4 claims
- 4278US7432290B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2004·Granted Oct 7, 2008·6 cites·2 claims
- 4377US11866411B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2021·Granted Jan 9, 2024·0 cites·10 claims
- 4477USRE49582ETherapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jul 18, 2023·0 cites·57 claims
- 4577US9856279B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 4677US9309227B2N-biphenylmethylbenzimidazole modulators of PPARGSCRIPPS RESEARCH INST·Filed 2012·Granted Apr 12, 2016·2 cites·11 claims
- 4776US10988448B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·0 cites·5 claims
- 4875US5166364AMevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing sameSQUIBB & SONS INC·Filed 1991·Granted Nov 24, 1992·12 cites·4 claims
- 4974US9657004B2Pyruvate kinase M2 modulators, therapeutic compositions and related methods of useAGIOS PHARMACEUTICALS INC·Filed 2015·Granted May 23, 2017·1 cites·3 claims
- 5073US7919520B2Inhibitors of taceVERTEX PHARMA·Filed 2008·Granted Apr 5, 2011·1 cites·3 claims
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeffrey O. Saunders files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →